Brokerages Set Humana Inc. (NYSE:HUM) PT at $249.91

Humana Inc. (NYSE:HUM) has been given a consensus rating of “Hold” by the twenty-eight ratings firms that are presently covering the firm, Marketbeat reports. Four research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and nine have given a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $270.4783.

Several brokerages have recently weighed in on HUM. Leerink Partners increased their price target on Humana from $185.00 to $255.00 and gave the company a “market perform” rating in a research note on Thursday, April 30th. Mizuho increased their price target on Humana from $290.00 to $335.00 and gave the company an “outperform” rating in a research note on Wednesday, May 20th. Royal Bank Of Canada increased their price target on Humana from $189.00 to $246.00 and gave the company a “sector perform” rating in a research note on Thursday, April 30th. Truist Financial increased their price target on Humana from $220.00 to $270.00 and gave the company a “hold” rating in a research note on Thursday, April 30th. Finally, The Goldman Sachs Group increased their price target on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a research note on Thursday, April 30th.

Institutional Investors Weigh In On Humana

Several large investors have recently added to or reduced their stakes in HUM. Montag A & Associates Inc. grew its stake in Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares during the period. CoreCap Advisors LLC grew its stake in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares during the period. Fideuram Asset Management Ireland dac acquired a new stake in Humana during the fourth quarter worth approximately $27,000. Reflection Asset Management acquired a new stake in Humana during the fourth quarter worth approximately $29,000. Finally, Rosenberg Matthew Hamilton grew its stake in Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 68 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Price Performance

Shares of HUM opened at $302.69 on Wednesday. The stock has a market cap of $36.34 billion, a PE ratio of 32.37, a PEG ratio of 2.23 and a beta of 0.68. The business has a 50-day simple moving average of $223.76 and a two-hundred day simple moving average of $227.71. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana has a 12-month low of $163.11 and a 12-month high of $315.66.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The business’s quarterly revenue was up 23.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Analysts anticipate that Humana will post 9.01 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. Humana’s dividend payout ratio is presently 37.86%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.